Joint Controllership Arrangement with regard to the Union product database (UPD)

Follow up EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma, Online, European Medicines Agency, Amsterdam, the Netherlands, 24 May 2024

Report - Follow up EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma

Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Evicel, human fibrinogen,human thrombin, Date of authorisation: 05/10/2008, Revision: 18, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Aclasta, zoledronic acid, Date of authorisation: 15/04/2005, Revision: 35, Status: Authorised

ICH reflection paper on pursuing opportunities for harmonisation in using real-world data to generate realworld evidence, with a focus on effectiveness of medicines

ICH E2D Post-approval safety data management - Scientific guideline

New pilot programme to support orphan medical devices

European Shortages Monitoring Platform Essentials and Industry Reporting Requirements, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 June 2024, 10:00 (CEST) to 24 June 2024, 12:30 (CEST)